| Value | Shares | ↓ Weighting | ||||||
|---|---|---|---|---|---|---|---|---|
| No holdings reported for quarter Q2 2012 | ||||||||
Top long-term holdings
| Name | Quarters owned | Latest quarter owned | Max weighting |
|---|---|---|---|
| RENAISSANCERE HOLDINGS LTD | 39 | Q2 2024 | 10.4% |
| ENSTAR GROUP LIMITED | 39 | Q2 2024 | 9.5% |
| NOVO-NORDISK A S | 39 | Q2 2024 | 10.6% |
| BERKSHIRE HATHAWAY INC DEL | 39 | Q2 2024 | 6.9% |
| MASTERCARD INCORPORATED | 39 | Q2 2024 | 0.9% |
| CONOCOPHILLIPS | 39 | Q2 2024 | 0.1% |
| ABBOTT LABS | 39 | Q2 2024 | 0.1% |
| PHILLIPS 66 | 39 | Q2 2024 | 0.0% |
| PTC INC | 37 | Q2 2024 | 13.1% |
| BERKSHIRE HATHAWAY INC DEL | 37 | Q2 2024 | 2.6% |
View Lagoda Investment Management, L.P.'s complete holdings history.
Latest significant ownerships (13-D/G)
| Filed | Shares | Percentage | |
|---|---|---|---|
| VOLITIONRX LTD | February 14, 2024 | 3,728,600 | 4.7% |
| DIGIMARC CORP | February 14, 2019 | 226,177 | 1.9% |
| T2 Biosystems, Inc.Sold out | February 14, 2019 | 0 | 0.0% |
| SENOMYX INC | February 14, 2018 | 2,043,935 | 4.2% |
View Lagoda Investment Management, L.P.'s complete significant-ownership history.
Latest filings
| Type | Filed |
|---|---|
| 13F-HR | 2024-08-14 |
| 13F-HR | 2024-05-15 |
| 13F-HR | 2024-02-14 |
| SC 13G/A | 2024-02-14 |
| 13F-HR | 2023-11-14 |
| 13F-HR | 2023-08-14 |
| 13F-HR | 2023-05-15 |
| 13F-HR | 2023-02-14 |
| SC 13G/A | 2023-02-14 |
| 13F-HR | 2022-11-14 |
View Lagoda Investment Management, L.P.'s complete filings history.
All filings
- Holdings (13F-HR)
- Significant ownership (13-D/G)
- Insider transactions (4, 5, 6)
- Events (8-K)
- Shareholder votes (proxy)
View complete filings history.